https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=10009
No pharmaceutical opinion available for this interaction.
Omeprazole by increasing gastric pH may decrease the solubility, absorption, and plasma concentration of Rilpivirine.
Possible decrease of clinical efficacy and risk of possible development of resistance to antiretroviral class.
Avoid association.
Cabenuva : No anticipated interaction so no adjustments necessary.
Antiretroviral not influenced by gastric pH such as bictegravir, dolutegravir or doravirine.
–
Contraindicated. Use alternative.
See rilpivirine + famotidine and rilpivirine + antacids.
–
–
Reference number |
---|
# patients |
HIV |
Dose |
Frequency |
AUC |
Cmax |
Cmin |
3555 |
---|
16 |
- |
150 mg * |
QD |
- 40 % |
- 40 % |
- 33 % |
3555 |
---|
15 |
- |
20 mg |
QD |
- 14% |
- 14% |
Ref #3555 : * The Interaction study has been performed with a dose higher than the recommended dose (25 mg QD) assessing the maximal effect on the coadministered drug.